This is a statistically cheap stock sitting on a deteriorating earnings base. A Price/Sales of 0.2 and Price/Book of 1.4 suggest deep value optics, but the Forward P/E of 37.6 combined with EPS Next Year estimated at -$3.40 signals a sharp earnings collapse ahead. The Altman Z-Score of 2.6 places the company in a gray zone—neither distressed nor safe—while a Piotroski F-Score of 3 confirms weak financial quality. The market is not mispricing growth here; it is discounting a cyclical downturn with negative forward earnings and a -12.70% operating margin.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.